TradingNote
Gurus

Top Investors

Warren BuffettCathie WoodLi LuRay DalioBill AckmanView all Top Investors
Archive
Industry

Technology & Software

Services-Prepackaged SoftwareComputer Programming & Data ProcessingView all Technology & Software
Research

NRSNW

NeuroSense Therapeutics Ltd.

Investor Moves

InvestorPortfolio ValuePortfolio ChangePosition ChangeAvg Buy PriceCurrent Price
Ken GriffinCitadel Advisors
$-7.0K
ExitQ1 2025
$7.0k
--
--
Ken GriffinCitadel Advisors
$3.2K
AddQ4 2024
$3.2k
--
--
Ken GriffinCitadel Advisors
$-2.3K
TrimQ3 2024
$2.3k
--
--
Trade NRSNW

About NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd. is an Israeli clinical-stage biotechnology firm dedicated to pioneering novel therapies for severe neurodegenerative conditions. Its most advanced investigational asset is PrimeC, an innovative oral compound specifically engineered to address amyotrophic lateral sclerosis (ALS). Beyond its lead program, the company boasts a preclinical pipeline featuring StabiliC, aimed at Parkinson's disease, and CogniC, targeting Alzheimer's disease. Established in Herzliya, Israel, in 2017, NeuroSense Therapeutics continues to advance its therapeutic initiatives.

CEO
Alon Ben-Noon
IPO Date
Dec 9, 2021

Market Data

OpenThe first traded price for the current trading session.
$0.17
HighThe highest traded price in the current trading session.
$0.19
LowThe lowest traded price in the current trading session.
$0.1451
VolumeTotal shares traded during the current trading session.
256
52W HighThe highest traded price over the past 52 weeks.
$0.30
52W LowThe lowest traded price over the past 52 weeks.
$0.1451

Valuation

Market CapCompany equity value based on share price multiplied by shares outstanding.
$3.6M
Enterprise ValueMarket cap plus debt and other claims, less cash and equivalents.
$19M

Financials

Free Cash FlowOperating cash flow minus capital expenditures from the latest annual cash flow statement.
$-7.7M
RevenueTotal sales from the latest annual income statement.
$0
Net IncomeProfit after expenses and taxes from the latest annual income statement.
$-11M
CashCash and equivalents, or cash plus short-term investments, from the latest balance sheet.
$166k
DebtTotal debt from the latest balance sheet.
$170k

Events

EarningsJun 22

EPS est. -0.0847

Modern Market Industries

AI & Compute

  • Semiconductors & Accelerators
  • Cloud & AI Platforms
  • Data Center & Networking

Software & Digital

  • Enterprise Software
  • Cybersecurity
  • DevTools & Observability
  • Consumer Internet & Marketplaces
  • Digital Advertising & Media

Healthcare

  • GLP-1 & Metabolic Health
  • Biotech & Oncology
  • Medical Devices & Diagnostics
  • Healthcare Services
  • Pharmaceuticals

Finance & Energy

  • Banks & Capital Markets
  • Asset Management & Exchanges
  • Insurance
  • Payments & Fintech
  • Digital Assets
  • Oil, Gas & Fuels

Modern categories

  • AI & Compute Infrastructure
  • Software & Digital Platforms
  • Healthcare Innovation
  • Financial Infrastructure
  • Energy & Grid

Detailed industries

  • Semiconductors & Accelerators
  • Cloud & AI Platforms
  • Data Center & Networking
  • Enterprise Software
  • Cybersecurity
  • DevTools & Observability
  • Consumer Internet & Marketplaces
  • Digital Advertising & Media

Action types

  • Investor actions
  • Insider Trades
  • Congress Trades
  • Stocks

Browse

  • Archive
  • Industries
  • Categories
  • Investors
  • Watchlist
© 2026 TradingNote
ArchiveIndustriesCategoriesInvestorsWatchlist